Find a Doctor

Ichiro Sakuma
IS
Areas of Expertise

Ichiro Sakuma

Pharmaceutical And Medical Devices Agency
Male

Bio

Ichiro Sakuma is in Tokyo, Japan. They have been an author on 165 peer reviewed articles in the past 15 years.

Areas of Expertise

Contact

Tokyo, 10000, JP

81-3-3506-9407

Latest Research

Latest Advance
Study
  • Condition: Atherosclerotic Cardiovascular Disease in the Elderly
  • Journal: Circulation
  • Treatment Used: Ezetimibe
  • Number of Patients: 3796
  • Published —
In this study, researchers evaluated the safety and effectiveness of using ezetimibe to prevent cardiovascular events in older patients.
Latest Advance
Study
  • Condition: Diabetes
  • Journal: Scientific reports
  • Treatment Used: Anagliptin vs Sitagliptin
  • Number of Patients: 353
  • Published —
The study compared Anagliptin vs Sitagliptin for low-density lipoprotein cholesterol in patients with diabetes.
Latest Advance
Study
  • Condition: Non-valvular atrial fibrillation
  • Journal: International journal of cardiology
  • Treatment Used: Rivaroxaban
  • Number of Patients: 7141
  • Published —
This study evaluated the efficacy and safety of rivaroxaban for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation.

Clinical Trials

This doctor has not participated in any recent clinical trials.

All Publications
View All

Publication
Study
  • Journal: Journal of atherosclerosis and thrombosis
  • Published —
Differential Effects of DPP-4 Inhibitors, Anagliptin and Sitagliptin, on PCSK9 Levels in Patients with Type 2 Diabetes Mellitus who are Receiving Statin Therapy.
Publication
Study
  • Journal: Endocrine journal
  • Published —
Effects of dapagliflozin on renin-angiotensin-aldosterone system under renin-angiotensin system inhibitor administration.

Contact

Tokyo, 10000, JP

81-3-3506-9407

Insurance

Contact them to find out if they accept your insurance plan.